Related Experiment Video
Updated: Aug 10, 2026

Colon Ascendens Stent Peritonitis (CASP) - a Standardized Model for Polymicrobial Abdominal Sepsis
Published on: December 18, 2010
[Antibiotic treatment of peritonitis]
1Département d'Anesthésie, Hôpital Saint-Joseph, Paris.
Abstract:
Secondary peritonitis usually results from perforation of a digestive tract organ. The bacterial contamination depends on the site of the perforation (supra or infra mesocolic) and the clinical setting (community or nosocomial). Although bacteriological specimens have not been proven to be diagnostic in community-acquired peritonitis, they are nevertheless mandatory in the nosocomial setting due to the multiresistant nature of the pathogens. Experimental models have evidenced a biphasic course in peritonitis with microbial synergism between aerobic and anaerobic pathogens. These experimental studies have also evidenced the importance of treating enterobacteria and strict anaerobic pathogens. The treatment of community-acquired peritonitis should be targeted against Gram negative bacilli, strict anaerobic germs and enterococci. Resistant Gram negative bacilli and enterococci are the target bacteria for nosocomial peritonitis. Doses should be adapted to renal function and hemodynamic conditions using antibiotics with proven efficacy on susceptibility tests. The theoretical duration of treatment is a question of debate and should be adapted to each individual case.
Insights
Secondary peritonitis, often from organ perforation, requires targeted antibiotic treatment. Effective management depends on identifying pathogens like Gram-negative bacilli and anaerobes, especially in nosocomial infections.
Area of Science:
- Infectious Diseases
- Microbiology
- Surgical Pathology
Context:
- Secondary peritonitis arises from digestive organ perforation.
- Bacterial contamination varies by perforation site (supra/infra mesocolic) and clinical setting (community/nosocomial).
- Bacteriological specimens are crucial for nosocomial peritonitis due to multidrug-resistant pathogens.
Purpose:
- To outline the microbiological considerations and treatment strategies for secondary peritonitis.
- To differentiate treatment approaches for community-acquired versus nosocomial peritonitis.
- To emphasize the importance of targeting specific bacterial pathogens in peritonitis management.
Summary:
- Peritonitis follows a biphasic course with aerobic and anaerobic pathogen synergism.
- Community-acquired peritonitis treatment targets Gram-negative bacilli, anaerobes, and enterococci.
- Nosocomial peritonitis requires targeting resistant Gram-negative bacilli and enterococci.
Impact:
- Informed antibiotic selection based on pathogen susceptibility and clinical setting.
- Highlights the need for dose adjustment based on renal function and hemodynamics.
- Contributes to optimizing treatment duration and patient outcomes in peritonitis.
More Related Videos
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Acute Pyelonephritis II: Diagnostic Studies and Management
Urine Studies II: Urine Culture and Sensitivity Test

